Trials / Terminated
TerminatedNCT04893382
Inflammatory Consequences of Crystalloids in Severely Burned Patients
Deciphering the Inflammatory Consequences of Crystalloids Used in the Resuscitation of Severely Burned Patients
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM) · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a pilot study, but the investigators will also observe key immunological events with potential significance. The global objective is to study the inflammatory profiles of PlasmaLyte and Ringer's Lactate used in the initial massive fluid resuscitation of severely burned patients. On the long term, the investigators will identify the crystalloid that prevents hyperactivation of macrophages and death of severely burned patients.
Detailed description
The investigators have 4 specific objectives. First, the investigators will compare the activation profiles of macrophages and neutrophils in patients admitted to the severely burned unit with regards to the crystalloids used. Secondly, the investigators will assess the differences in the SOFA scores according to the crystalloids used. Thirdly, the investigators will evaluate the impact of crystalloids in the quality of skin grafts performed on severely burned patients. Lastly, with the help of a patient partner, the investigators will determine the right immunological terminology of the study for a non-scientific population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | PlasmaLyte for fluid resuscitation | Fluid resuscitation is a critical and essential part in the treatment of severely burned patients. Patients randomized for this arm will be submitted to PlasmaLyte infusion (as clinically prescribed). |
| PROCEDURE | Ringer's Lactate for fluid resuscitation | Fluid resuscitation is a critical and essential part in the treatment of severely burned patients. Patients randomized for this arm will be submitted to Ringer's Lactate infusion (as clinically prescribed). |
Timeline
- Start date
- 2021-10-17
- Primary completion
- 2025-02-19
- Completion
- 2025-02-19
- First posted
- 2021-05-19
- Last updated
- 2025-02-21
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04893382. Inclusion in this directory is not an endorsement.